HLB PHARMACEUTICAL CO., LTD. Logo

HLB PHARMACEUTICAL CO., LTD.

Develops and manufactures pharmaceuticals, quasi-drugs, and new peptide-based drugs.

047920 | KO

Overview

Corporate Details

ISIN(s):
KR7047920004
LEI:
Country:
South Korea
Address:
경기도 남양주시 경강로 27, 남양주시

Description

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-27 00:00
정기주주총회결과
Korean 25.1 KB
2024-03-21 00:00
주요사항보고서(자기전환사채매도결정)
Korean 29.5 KB
2024-03-19 00:00
감사보고서제출
Korean 18.5 KB
2024-03-19 00:00
사업보고서 (2023.12)
Korean 1.2 MB
2024-03-19 00:00
[기재정정]의결권대리행사권유참고서류
Korean 164.6 KB
2024-03-19 00:00
[기재정정]의결권대리행사권유참고서류
Korean 164.7 KB
2024-03-19 00:00
[기재정정]의결권대리행사권유참고서류
Korean 165.6 KB
2024-03-19 00:00
[기재정정]의결권대리행사권유참고서류
Korean 165.5 KB
2024-03-19 00:00
[기재정정]주주총회소집공고
Korean 181.6 KB
2024-03-19 00:00
[기재정정]주주총회소집공고
Korean 181.6 KB
2024-03-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.0 KB
2024-03-12 00:00
주주총회집중일개최사유신고
Korean 5.0 KB
2024-03-12 00:00
주주총회소집결의 (정기주주총회)
Korean 12.5 KB
2024-03-12 00:00
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 18.4 KB
2024-03-12 00:00
의결권대리행사권유참고서류
Korean 85.1 KB

Automate Your Workflow. Get a real-time feed of all HLB PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.